Forbes September 11, 2024
Robert Hart

Topline

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition from Mounjaro maker Eli Lilly, pharma titans like Pfizer and biotech upstarts.

Key Facts

When Will Weight Loss Pills Be Available?

The best weight loss drugs on the market at the moment, Lilly’s tirzepatide and Novo’s semaglutide, are only available as injections, which many people find off putting and can be challenging and expensive to produce. Pharma titans like Pfizer, Roche and Novo, are all racing to crack into this lucrative sector with alternatives like weight loss pills and early data suggests they could be as, or even more, effective...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Pharma / Biotech, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article